Thomas A. Edwards - 20 May 2021 Form 4 Insider Report for ChemoCentryx, Inc.

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
20 May 2021
Net transactions value
$0
Form type
4
Filing time
24 May 2021, 19:39:54 UTC
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Award $0 +7,726 +6.4% $0.000000 127,583 20 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Stock Option (right to buy) Award +4,504 4,504 20 May 2021 Common Stock 4,504 $10.06 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock awarded on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.
F2 The option granted on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.
F3 Not applicable.